1995
DOI: 10.1007/bf02425162
|View full text |Cite
|
Sign up to set email alerts
|

Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation

Abstract: Heparin is the mainstay of anticoagulation for the extracorporeal circuit although the complex abnormalities of the coagulation system in critically ill patients are associated with a considerable risk of bleeding. Alternative therapeutic agents and physical strategies (prostacyclin, low molecular weight heparin, sodium citrate, regional anticoagulation, heparin bonding and attention to circuit design) may reduce the risk of bleeding but expense and difficulty in monitoring are disadvantages.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
34
1

Year Published

1998
1998
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(35 citation statements)
references
References 60 publications
0
34
1
Order By: Relevance
“…Heparin is widely used as an anticoagulant in hemodialysis (48). Although no significant difference in the prevalence of A␤2M amyloidosis was found between patients on continuous ambulatory peritoneal dialysis and those on hemodialysis carefully matched for time on dialysis and age at the onset of dialysis (49), the present study suggests that heparin could exert a subtle effect for the development of A␤2M amyloidosis under some clinical conditions.…”
Section: Molecular Environment Of A␤2m Amyloid Deposition In Vivocontrasting
confidence: 49%
“…Heparin is widely used as an anticoagulant in hemodialysis (48). Although no significant difference in the prevalence of A␤2M amyloidosis was found between patients on continuous ambulatory peritoneal dialysis and those on hemodialysis carefully matched for time on dialysis and age at the onset of dialysis (49), the present study suggests that heparin could exert a subtle effect for the development of A␤2M amyloidosis under some clinical conditions.…”
Section: Molecular Environment Of A␤2m Amyloid Deposition In Vivocontrasting
confidence: 49%
“…Even though the retrospective design of this study did not allow a direct comparison with other anti-haemostatic strategies, our experience strongly suggests that prostacyclin does not carry an unduly high risk of bleeding complications or substantial haemodynamic intolerance while keeping the extracorporeal circuit patent long enough to allow the delivery of an adequate dose of renal replacement therapy. Platelets are considered key factors in the genesis of circuit clotting during extracorporeal circulation, whatever the anticoagulation protocol used [3,5,22,31]. Extracorporeal circulation activates platelets by foreign surface contact, shear stress, air-blood interaction and mechanical damage [22].…”
Section: Discussionmentioning
confidence: 99%
“…Extracorporeal circulation activates platelets by foreign surface contact, shear stress, air-blood interaction and mechanical damage [22]. By inducing platelet dysfunction and consumption, these stimuli can paradoxically increase the risk of both circuit clotting and patient bleeding [5,10,31,32,33,34,35,36].…”
Section: Discussionmentioning
confidence: 99%
“…Successful application of CRRT, however, depends on adequate extracorporeal circuit (EC) life. The duration of EC life in turn hinges on anticoagulation [5]. The need for anticoagulation has to be balanced against the increased risk of bleeding in high-risk patients.…”
Section: Introductionmentioning
confidence: 99%